Trial intelligence / Profile preview

Celecoxib for Pain Management After Tonsillectomy

NCT02934191Phase 2Completed

Sponsor
Children's Hospital of Philadelphia
Start
Jun 2016
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of celecoxib oral solution in postoperative pain (2 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoints: Difference in Number of Days Requiring Rescue Pain Medication and Difference in Amount of Rescue Pain Medication Consumed. Started Jun 2016; status: completed.

02

Drugs

celecoxib oral solution
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02934191.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02934191.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call